"Phospholipid Encapsulation Technologies for Enhanced Nutrient Delivery." Advanced Drug Delivery Reviews, 167, 89-104
The Egyptian Journal of Hospital Medicine
Stafford P, Abdelwahab MG, Kim DY, Preul MC, Rho JM, Scheck AC
Prior to the availability of enzyme-replacement therapy, individuals with LAL-D were treated with lipid lowering medication, liver transplant, and stem cell transplant, none of which corrected the multisystem nature of the disorder
Philip Rabito, M.D., a specialist in endocrinology, weight loss and wellness in New York City, shared in a previous interview with Fox News Digital that this new class of weight-loss drugs is positioned to "approach bariatric surgery level outcomes" although it doesn't come without risks
A licensed provider should review your health history, medications, symptoms, and goals before recommending a plan